Swastik Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.48 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 15.00 Cr
- Revenue Growth 27.20%
- Profit Growth 22.61%
- Ebitda 22.71%
- Net Worth 0.73%
- Total Assets 5.28%
About Swastik Lifescience
Swastik Lifescience Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 July 2007 and has a history of 17 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.48 M.
The company currently has active open charges totaling ₹15.00 Cr.
Vinod Kumar and Sanjay Aggarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01200DL2007PTC165518
- Company No.
165518
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2007
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Swastik Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Kumar  | Director | 26-Aug-2013 | Current |
| Sanjay Aggarwal | Director | 28-Aug-2015 | Current |
Financial Performance of Swastik Lifescience.
Swastik Lifescience Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 27.2% increase. The company also saw a substantial improvement in profitability, with a 22.61% increase in profit. The company's net worth moved up by a moderate rise of 0.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swastik Lifescience?
In 2015, Swastik Lifescience had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eco Polyfibres Private LimitedVinod Kumar and Sanjay Aggarwal are mutual person
Ecosmart Developers Private LimitedSanjay Aggarwal is a mutual person
Charges (Loans)
₹15.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2015 | Syndicate Bank | ₹15.00 Cr | Open |
How Many Employees Work at Swastik Lifescience?
Unlock and access historical data on people associated with Swastik Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swastik Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swastik Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
